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Background: Because species-specific gene expression is driven by species-specific regulation, understanding the
relationship between sequence and function of the regulatory regions in different species will help elucidate how
differences among species arise. Despite active experimental and computational research, relationships among
sequence, conservation, and function are still poorly understood.
Results: We compared transcription factor occupied segments (TFos) for 116 human and 35 mouse TFs in
546 human and 125 mouse cell types and tissues from the Human and the Mouse ENCODE projects. We
based the map between human and mouse TFos on a one-to-one nucleotide cross-species mapper, bnMapper,
that utilizes whole genome alignments (WGA).
Our analysis shows that TFos are under evolutionary constraint, but a substantial portion (25.1% of mouse and 25.85%
of human on average) of the TFos does not have a homologous sequence on the other species; this portion varies
among cell types and TFs. Furthermore, 47.67% and 57.01% of the homologous TFos sequence shows binding activity
on the other species for human and mouse respectively. However, 79.87% and 69.22% is repurposed such that it binds
the same TF in different cells or different TFs in the same cells. Remarkably, within the set of repurposed TFos, the
corresponding genome regions in the other species are preferred locations of novel TFos. These events suggest
exaptation of some functional regulatory sequences into new function.
Despite TFos repurposing, we did not find substantial changes in their predicted target genes, suggesting that CRMs
buffer evolutionary events allowing little or no change in the TFos – target gene associations. Thus, the small portion
of TFos with strictly conserved occupancy underestimates the degree of conservation of regulatory interactions.
Conclusion: We mapped regulatory sequences from an extensive number of TFs and cell types between human
and mouse using WGA. A comparative analysis of this correspondence unveiled the extent of the shared
regulatory sequence across TFs and cell types under study. Importantly, a large part of the shared regulatory
sequence is repurposed on the other species. This sequence, fueled by turnover events, provides a strong
case for exaptation in regulatory elements.
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Most eukaryotic gene regulation occurs at the level of
transcription [1,2]. This form of regulation involves the
interaction of transcription factors (TFs) with element
and function specific DNA sequences, referred to as cis-
regulatory modules (CRMs; reviewed by [3]). Their modu-
lar organization allows for elaborate regulatory mechanisms
and fine control of gene expression [4].
Evolutionary changes in CRMs have a profound effect
on species divergence. Many studies suggest that species
specific CRMs are the defining factor for species identity
[5-7]. Differences in human and chimpanzee, for ex-
ample, are almost completely due to changes in func-
tional noncoding sequence [8]. Efforts to locate the
“human gene” have only revealed differences in a small
number of genes [9-11]. Moreover, comparisons of organ-
isms at the extremes of eukaryotes show that the genes en-
coding TFs and signaling components (e.g. for temporal/
spatial gene expression patterns) are largely conserved [4].
Taken together, this evidence suggests a hierarchical
organization of regulatory networks. Modules at the top,
performing essential upstream functions, span large evo-
lutionary distances virtually unchanged, while lower level
modules, involved in peripheral sub-networks, show a
higher level of adaptation [12]. Under this model, part of
the regulatory material must be under purifying selection
and thus conserved between any two species of sufficiently
small evolutionary divergence.
Evidence of conservation of regulatory sequence among
species has inspired a series of computational methods.
Some of these methods use machine learning and phylo-
genetic profiling to discover CRMs (reviewed by [13]),
others use comparative analysis to identify genomic ma-
terial under purifying evolutionary constraint as a repre-
sentative of the functional genome (reviewed by [14]).
At the same time, a number of experimental studies
suggest that while sequence might encode enough infor-
mation to drive TF binding [15], the way this information
is encoded is not trivial – similar sequence does not ne-
cessarily translate in similar function and vice versa. For
example, regulatory elements have been found to tolerate
sequence rearrangements [16] or even be under positive
selection while maintaining the downstream regulatory
machinery unchanged [17,18]. Recently, it was found that
GATA1 changes its motif preferences during cell differen-
tiation [19], serving as an example of TFs having multiple
preferred motif sequences [20] while maintaining a regula-
tory function.
Both computational and experimental approaches have
provided valuable insight into the regulatory portion of the
genome, but they have limitations. Computational methods
are biased toward well-annotated and evolutionarily con-
served genomic regions, indeed comparative analyses based
on evolutionary conservation alone ignore species-specificfunctional elements. Experimental approaches based on
direct genome wide measurements of TFos are a powerful
resource for the identification and analysis of TF binding
sites. However, the number of cell types and TFs assessed
so far has often been limited.
With some studies pointing at conservation, others at
divergence, and others yet at turnover of motifs and the
importance of occupancy, the level of constraint on the
CRMs is still an open question. This apparently contra-
dicting evidence can be reconciled by considering con-
servation as specific to the TF or the cell type.
In this study, we combined several types of function-
associated datasets from a large number of TFs from a
wide variety of tissues and cell lines in both mouse and
human. Our main data source is ChIP-Seq experiments
performed by the mouse and human ENCODE projects.
These data give evidence on the locations where TF have
come close enough to the DNA to cross-link in cells. The
question remains whether these locations, termed TFos
[13], could represent direct binding to a specific motif in
the DNA or co-association with another TF. However,
there is evidence that the TFos are active in assays for
regulatory function at a far higher rate than non-occupied
DNA segments, or DNA segments predicted as regulatory
based on sequence motifs or conservation making them
likely to have regulatory function. We also used DNase I
Hypersensitive Sites (DHS) generated by the Human [21]
and the Mouse ENCODE [22] projects. DHS regions are
markers of regulatory DNA and have underpinned the
discovery of all classes of cis-regulatory elements including
enhancers, promoters, insulators, silencers and locus con-
trol regions. We conduced a comparative analysis, by inte-
grating TFos with human-mouse WGA, gene annotations,
and TF-gene associations. We have also compiled the data
and annotations derived from this study into a database to
serve as a resource in exploring the relationship between
sequence evolution and function of regulatory elements
(Additional file 1: Figure S1).
Results
An alignment based map for human-mouse TFos
Differences between present day genomes are the result of
a series of evolutionary events originating on their most
recent common ancestor [23]. Many of these events can
be explained under probability models and represented in
the form of WGA (See [24] for a review). Sequence that
has undergone a moderate number of evolutionary events
will appear aligned, while highly divergent regions will
usually be left un-aligned.
We used WGA to obtain a consistent map for TFos
across human and mouse (Figure 1(A)). These alignments
provide long, inferred homologous regions in the form
of chains of gapless blocks. They can account for inver-
sions, translocations, duplications, large-scale deletions,
Figure 1 We built a one to one map between the human and mouse genomes from their WGA. (A) The track diagram shows TFos
(unfilled features on outer tracks) and how they map to the other species (middle track). The thick part of the middle track is the mappable DNA.
The features on the middle track can be mapped on the other species and are: SeqCons if not overlapping features from the other species
(respective color), or FuncCons or FunctActive otherwise (green). The Venn diagrams use the same color code to show the amount (rounded to
the closest Mb) of mappable material from one species to the other for DNA sequence, TFos, and DHS. For example, human TFos cover 121 Mb
of the human genome. When mapped to mouse, these TFos cover 83 Mb of the mouse genome and 12 Mb of the sequence covered also by
mouse TFos. The diagram for DHS is labeled in a similar fashion. (B) The distribution of mappable TFos nucleotides across cell types. The box-plot
for each cell type summarizes the distribution of values for the fraction of nucleotides covered by TFos that can be mapped on the other species.
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chained blastz [25] alignments available from the UCSC
browser [26] and the 12-way mammalian WGA from the
EPO pipeline [27] available from Ensembl version 65 [28].
To choose the most appropriate alignment for our map-
pings we used several criteria: symmetry, coverage, feature
enrichment, and other method specific properties.
Symmetry is important for unambiguously mapping
features from one genome to the other and back. The
EPO based map is inherently symmetric; we only need to
extract human-mouse alignments. We remove segmental
duplications based on criteria such as the score or the
length of the alignment to obtain an unambiguous map.
UCSC alignments, on the other hand, are based on blastz
pairwise alignments, which are not symmetric – a human-
mouse alignment is different from a mouse-human align-
ment in general. However, it is possible to circumvent the
problem by using a netting procedure and chaining again
only the first layer in the resulting net. This corresponds
to heuristically cleaning overlapping chains based on their
score. The resulting reciprocal map is identical to the
one derived from the mouse-human alignments at the
cost of losing around 10% sequence coverage on both
species [29].UCSC alignments align a slightly larger fraction of
the mouse genome (31% vs. 28% for UCSC and EPO re-
spectively) to human. However, EPO alignments can as-
sign a substantially higher amount of inserted mouse
sequence (28% vs. 1.9%). In total 65.7% of the mouse gen-
ome remains unmapped by UCSC alignments and 42.5%
by EPO alignments.
Next, we computed the number of features that each
alignment could map on the other species for all available
cell types in human and mouse. We found that UCSC
alignments mapped more features on the other species
(Additional file 1: Figure S2 and Tables S4-S6).
Based on the above considerations, we adopted the re-
ciprocal UCSC alignments. The alignments and the com-
parative pipeline described here were adopted by the
Mouse Encode Consortium for the cross-species mapping
of TFos.
Function and sequence conservation of TFos
We processed TFos generated by ChIP-Seq for 206 hu-
man and 55 mouse cell lines and tissues [22], with a
variable number of factors for each cell or tissue (from 1
to 109 for human and from 1 to 38 for mouse). The data
were generated by the Human and the Mouse ENCODE
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conducted following the human ENCODE guidelines
[30]. Data processing, including Irreproducible Discovery
Rate (IDR) analysis, was done using a uniform data pro-
cessing pipeline for both datasets.
Elements recovered by the ChIP-Seq experiments and
the subsequent peak-calling pipeline were subjected to
thresholds for False Discovery Rate at 1% and IDR at 2%.
We then filtered these sets to retain only those TFos show-
ing DHS enrichment, thereby increasing our confidence
in the functional role of the filtered elements. Roughly
41.63% of ChIP-Seq peaks were filtered out from each spe-
cies by DHS filtering. The resulting data contained 5330864
and 727680 elements covering 121.08 Mb and 31.6 Mb of
the genome for human and mouse respectively (Additional
file 1: Table S3). The higher human coverage is due to the
larger number of assays available in human.
We asked whether the selected putative regulatory ma-
terial is significantly conserved. At the sequence level,
we find that the fraction of TFos intersecting homolo-
gous regions is higher than one would expect by chance
(Binomial test 0.99% CI: (0.7218, 0.7228) and 0.99% CI:
(0.6908, 0.6936) with expected values of 0.3129 and 0.3648
for human and mouse respectively). At the TF-binding ac-
tivity level (i.e., having TF occupancy by any TF), mapped
human and mouse TFos overlapped TFos on the other
species more often than expected by chance (Binomial test
0.99% CI: (0.5358, 0.5371) and 0.99% CI: (0.7883, 0.7913)
with expected values 0.0231 and 0.0857 for human and
mouse respectively). Significant conservation at the
TF-binding activity level continues to hold largely for in-
dividual TFs-cell pairs (Additional file 1: Figures S3-S4).
These results indicate that most of these human and
mouse regulatory regions have been under selective pres-
sure both at the sequence and functional level.
Despite the selective pressure on the TFos, the data sug-
gest extensive evolution of the regulatory material be-
tween human and mouse. On average 74.2% and 74.9% of
TFos can be mapped on the other species resulting in a
36.1% and 31.4% of regulatory sequence coverage that
is lineage-specific for human and mouse respectively
(Figure 1(B) and Additional file 1: S5-S12). Importantly,
we found that the extent to which the remaining regula-
tory material is conserved varies substantially between
species and among cell types and TFs. The variability fits
with previous studies on smaller numbers of TFs and cell
types, which have emphasized both, conservation of TFos
[31] and extensive regulatory sequence evolution [32].
Binding signal differences between functionally and
sequence conserved TFos
We focus our TFos comparative analysis on two Tier 1
ENCODE cell lines and their mouse analogs as chosen
by the Mouse ENCODE consortium. The data consist of17 TFs from human chronic myelogenous leukemia cell
line (K562, [33]) and mouse erythroleukemia cell line
(MEL, [34]); and 15 TFs from lymphoblast cell lines
(GM12878 vs. CH12) (Additional file 1: Table S2). In
total we have thus selected 442527 and 215251 TFos
covering 33.61 Mb and 18.77 Mb on human and mouse
respectively. We mapped TFos of a species to homolo-
gous locations in the other and asked what function do
those sites show.
The homologous site of a TFos can be: (i) not occu-
pied by TFs, in which case we call the TFos SeqCons; (ii)
repurposed, thus active in another cell or bound by an-
other factor in the same cell type, in which case we call
the TFos FunctActive; or (iii) bound by the same factor
on the same cell type, in which case the TFos is called
FunctCons. SeqCons and FunctActive elements represent
differences in human and mouse TF binding patterns due
to TFos loss, gain, or both. Turnover occurs in the case of
loss and gain of the same TFos at different, but nearby,
positions. However, more complex differences can arise
when the loss of one TFos is followed by compensatory
gains of TFos of other TFs. For the pairs of analogous cell
types in human and mouse, the largest proportion of TFos
(considered together) are FunctActive, while the relative
proportions of FunctCons and SeqCons vary between cell
types and species (Figure 2(A)).
Conservation of occupancy in the other species was
associated with peak signal strength for several cell type-
TF pairs. For example, binding signal on FunctCons or
FunctActive elements was higher than that on SeqCons
elements for 59% and 50% of cell type-TF combinations
for human and mouse respectively (with a Bonferroni-
corrected error rate of 1%; Additional file 1: Figures S13,
S14). Overall, FunctCons peak signal is on average 1.3 and
1.9 times larger than SeqCons peak signal on human and
mouse respectively (Additional file 1: Table S1).
TF binding site turnover and TFos repurposing
If SeqCons and FunctActive elements are the result of
turnover of TF binding sites (TFBS) in human and mouse,
then we should observe TFBS close to regions orthologous
to TFBS on the other species. We discovered TFBS using
motif discovery and motif matching on TFos for both spe-
cies and analyzed their alignment. We found that for sev-
eral TFs, SeqCons TFBS map within 150 bp of a TFBS on
the other species. On average, 51% and 48% of SeqCons
TFBS have been subject to turnover in a 150 bp neighbor-
hood for human and mouse respectively (Figure 2(B)).
The large number of FunctActive elements (Figures 2(A)
and Additional file 1: S15, S16) suggests recycling of TFos
among cells and TFs. We examined this more carefully
with a novel approach, based on the intuition that exten-
sive recycling would allow any set of TFos in a comparison
species to identify the occurrence of specific TFos in the
Figure 2 Conservation and re-use of TFos. (A) The distribution of SeqCons, FunctActive, and FunctCons regulatory elements summarized
for all human mouse analogous cell lines (Additional file 1: Table S2). In both cell lines, a small fraction of mappable regulatory elements is
FunctCons (33% and 15% cell average for human and mouse respectively). A larger fraction (46% and 50% cell average for human and mouse
respectively) is FunctActive (plots for each cell are in Additional file 1: Figures S15, S16). (B) Loss and gain of TF binding sites. We used TFos in
our data to discover TF binding sites (TFBS) on both species. We mapped human (respectively mouse) TFBS to mouse (respectively human) and
computed their distance to the closest mouse (respectively human) TFBS of the same TF on an analogous cell. Among these TFBS those with a
positive distance but less than 150 bp contribute to the corresponding bar in the human (respectively mouse) subplot. In other words, each bar
is the count of TFBS that were lost and gained within a 150 bp window of the original site. (C) Reuse of FunctActive TFos between different
cells and factors. A point on the scatterplot indicates the number of TFos of the corresponding assay in the reference species that can
be classified as FunctCons or FunctActive when considering a fixed size set of randomly chosen assays in the comparison species. We
performed multiple computations for each chosen size of such sets. Lines indicate the accumulated number of FunctCons, FunctActive,
and Seqcons TFos. In this figure, about 93% of the (Mel, Max) assay is covered by TFos from just 35% of the query assays (plots for other
cells/TFs in Additional file 1: Figures S17, S18).
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duct this analysis, we sampled (multiple times) mapped
TFos from k assays from the comparison species, took the
union of these TFos, and computed the number of TFos a
given assay (in the reference species) shares with this
union. The results strongly support extensive recycling of
TFos. Specifically, we find that about 93% of the (Mel,
Max) assay is covered by TFos from just 35% of the query
assays. As k increases, coverage saturates (Figures 2(C)
and Additional file 1: S17, S18). This ability of different
assays in the comparison species to capture TFos in the
reference species is substantially different than what isobtained by simulating non-associated assays (Additional
file 1: Figure S19).
We tested the hypothesis that new TFos tend to arise
over existing TFos – active in other cells or occupied by
other factors. Under the null hypothesis, the fraction of
FunctActive elements with respect to the non-FunctCons
elements should not be significantly higher than the frac-
tion of the genome that can turn into a FunctActive TFos,
should a new TFos occur (See Methods for details). We
found that fraction to be higher than expected (One sided
Binomial test 99% CI: (0.377, 1.000) and (0.477, 1.000)
with expected values 0.010 and 0.028 for human and
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sites where new TFBS are likely to arise.
Turnover events or the appearance of novel TFBS
lead to compositional changes in CRMs. However, these
changes do not always reflect downstream in, for example,
the set of target genes. Following [35] we extracted a
set of TSS-enhancer connections based on synchronized
DHS activity during the transcription of a gene. Restrict-
ing on 15,736 human-mouse orthologous genes [22], we
were thus able to define putative target genes for 1928211
and 204758 TFos for human and mouse respectively. We
observe that, similarly to FunctCons TFos, about 39% and
43% of FunctActive TFos retained at least one putative
target gene for human and mouse respectively. Further-
more, the amount at which the set of target genes is con-
served across species is not significantly different between
the two classes of TFos (Kolmogorov-Smirnov test.
p-values: < 2.2e-16 and < 2.2e-16 for human and mouse
respectively). The example of the candidate enhancer
linked to the ACAP3 gene in human illustrates this situ-
ation (Figure 3). The DNA segment in mouse that is
orthologous to the human enhancer has been repurposed
such that it binds different TFs, but the mouse Acap3 gene
is still the presumptive target.
Discussion
We reported on the construction and use of a map of
functional elements between human and mouse based on
WGA. This map is consistent and symmetrical in that it
provides a one to one correspondence between genome
elements in both directions. Furthermore, it constitutes an
improvement over aligning TFos directly on the other spe-
cies guided by gene orthology; this approach is likely to
deteriorate with the distance of an element from the near-
est gene with an ortholog on the other species.Figure 3 Conservation of presumptive gene targets for a repurposed
and gene-TFos associations to determine whether the sets of target genes o
association data are based on a set of orthologous genes between hu
gene-TFos data are based on synchronized DHS activity during gene tr
cross-species map. In the figure, we show a human TFos of Mxi on K5
FunctActive, since its analogous location (broken oval linked by the da
mouse) in mouse is bound by other TFs on other cell types (not show
Incidentally, ACAP3 and Acap3 are orthologous and in our gene-gene
bind different TFs and are active in different cell types, but they shareUsing this mapping approach, we were able to recover,
on average, 75% and 73% of TFos in the other species, of
which 63% and 78% are bound by any TFs and 13% and
25% by the same TF for human and mouse respectively.
The rest of the regulatory material is species-specific ei-
ther at the sequence or functional level and is likely to
account for the phenotypic differences between human
and mouse [8,12]. However, some of the species-specific
material retains target genes suggesting that CRMs buf-
fer changes toward downstream regulation [36].
One potential difficulty, which affects this analysis, is
the variation that can be introduced by technical factors
such as signal thresholding or by differences in the envir-
onment of the cells being compared. By using data proc-
essed for reproducibility under the stringent standards
developed by the Human and Mouse ENCODE projects,
restricting to regions overlapping DHS for greater confi-
dence, considering the TF activity on analogous cell types,
and employing statistical controls we hope to have amelio-
rated these issues.
Previous studies have mapped the binding patterns of
TFs between species, including mouse and human, by
focusing on a single cell type and a few TFs (e.g., [32]).
While these important studies have revealed substantial
divergence in the binding patterns of TFs between species,
they do not explore FunctActive elements or related dy-
namics such as repurposing. One important conclusion in
our study is that the evolution of regulatory sequences
varies considerably among TFs and cell types, and further-
more we document which TFos fall into the various evolu-
tionary categories.
The traffic between noncoding functional and nonfunc-
tional DNA in a genome is two-way. On the one hand, loss
of a TFos can increase fitness, as dramatically illustrated
by changes in the regulation of pitx1 in three-spinedTFos. We combined cross-species gene-gene and TFos-TFos associations
f FunctCons and FunctActive TFos differ significantly. Gene-gene
man and mouse produced by the mouse ENCODE consortium,
anscription [35], and TFos-TFos associations are based on our
62 (empty oval) associated with PUSL1 and ACAP3. This TFos is
shed line with spaces between ovals indicating insertions in
n). However, its analogous site in mouse is linked to gene Acap3.
association set. The human TFos and its analogous site in mouse
a target gene.
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in a new environment. On the other hand, new functional
noncoding sequence can arise from nonfunctional se-
quence through turnover [37]. The differences between
the sizes of FunctActive and FunctCons pools suggests
another source of functional noncoding material traffic,
characterized by the exaptation of TFos into functional
noncoding material with novel TF or cell type activity
[38]. With a partial catalog of regulatory elements it is
hard to distinguish the newly created functional material
from the exapted one. However with ever-increasing num-
bers of experimental assays the picture should become
more clear.
Conclusions
Despite previous elegant studies, the level of constraint
on CRMs remains controversial. We provide further evi-
dence that TFos are more conserved than random se-
quence and that conservation is cell and TF specific.
Furthermore, we study the type of conservation of TFos
and observe that 47.67% and 57.01% of TFos conserved
at the sequence level for human and mouse respectively
have been repurposed and are active in cell types or bind
different TFs. We show how this sequence makes a case
for TFos exaptation into new function. Finally, we find
that repurposing does not necessarily lead to changes in
the TFos – target gene association.
Comparative studies of CRMs involve a mapping strat-
egy of regulatory elements, often by aligning elements or
reads on both genomes, possibly guiding mapping with
gene homologies. We implemented a multiple WGA
based process for TFos mapping. Using multiple WGA
we should have a more sensitive and consistent mapping
process. Importantly, the mapper can provide one-to-
one mappings between species, which is very useful dur-
ing analysis.
Methods
Data processing
ChIP-Seq data
We download all of the ChIP-Seq data generated by the
Human and the Mouse ENCODE from the ENCODE
DCC. The pipeline that filters the original ENCODE peaks
is available in the supplementary material.
Distal DHS-to-promoter connections
As described in [35] many cell-selective enhancers become
DHSs synchronously with the appearance of hypersensitiv-
ity at the promoter of their target gene. This has been used
to infer a genome-wide DHS/enhancer-promoter connec-
tion set. Using a conservative list of orthologous genes [22]
we inferred a list of correspondences between TFos regu-
lating human-mouse orthologous genes.EPO and UCSC based maps
We considered the EPO 12-way mammalian whole gen-
ome alignments from Ensembl project version 65 [28]
and the UCSC human mouse chain and net alignments
from the UCSC [26] genome browser to generate the
reciprocal maps. Details and programs for processing of
the alignments are available at https://bitbucket.org/bxlab/
mapper_comparisons.
Mapping strategy
We built and used a one-to-one nucleotide mapper
(bnMapper) to map elements between human and mouse.
The mapping is bijective, so reverse application of the
mapping to a mapped nucleotide, returns the original nu-
cleotide. Elements that span matching blocks of different
chains and elements that map to multiple chromosomes
are filtered out. The mapper and a detailed analysis of per-
formance between EPO and UCSC alignments are avail-
able at https://bitbucket.org/bxlab/mapper_comparisons.
Details on the mapping strategy are on Section 1.1 of the
Additional file 1.
Significance tests
For a given genomic region of coverage C, the number of
n randomly positioned features over the genome (length
L) would follow a Binomial (n, C/L). For significance of
TF conservation at the sequence level we set L, C, and n,
to be the length of the genome, total TF coverage, and
total number of peaks. A success event is an overlap of
1 bp with the one to one mappable sequence. Similarly,
for functional conservation, L, C, and n, are set to total
one to one mappable sequence, coverage of mapped
peaks, and number of mapped peaks overlapping with
peaks on the target genome, respectively.
For the paired Wilcoxon tests we consider all TFs
within a cell line that appear on both species. Ranks are
computed from FunctCons to SeqCons ratios of corre-
sponding TFs on each species.
To test that a new TFos is more likely to occur in an
existing TFos, possibly occupied by another TFs or active
in another cell, consider the following quantities with re-
spect to a fixed genome:
 The number of non-FunctCons TFos in this genome
not less than the number of new TFos in this
genome. The inequality accounts for TFos deletions
on the other genome. We write nFCo > = nFCt.
 Coverage of SeqCons of the other genome after
being mapped in this genome and FA elements in
this genome not less than regions in this genome
that would become FA should a new TFos occur.
The inequality accounts for those regions that would
become FunctCons should a new TFos appear. We
write Mo > = Mt.
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 The number of FunctActive Tfos in this genome.
We write FA.
Here we are making the assumption that FunctCons
elements have existed before human-mouse split and
FunctActive are a result of a deletion or creation (or
both) after the human-mouse split. Thus, the fraction
FA/nFCt is that of new elements that occurred in exist-
ing TFos involving other TFs or cell types, whether the
fraction Mt/L indicates the chance of a new TFos to be-
come FunctActive should it occur randomly in the gen-
ome. Under the alternative hypothesis, FA/nFCt >Mt/L.
However, because Mt/L < = Mo/L and FA/nFCo < = FA/
nFCt, it suffices to show that FA/nFCo > = Mo/L. Notice
that we observe all the quantities in the last expression.
Data access
UCSC alignments can be downloaded from the UCSC
website http://hgdownload.soe.ucsc.edu/goldenPath/hg19/
vsMm9/.
UCSC bijective (netted) alignments, the list of one-to-
one orthologous genes, the list of DHS-gene associa-
tions, and the list of Mouse ChIP-Seq TFos and DHSs
can be downloaded from the Mouse ENCODE web
portal http://mouse.encodedcc.org/data and http://www.
mouseencode.org/.
The mapping software can be freely downloaded as part
of the bx-python software library from https://bitbucket.
org/james_taylor/bx-python/wiki/Home.
Ensembl EPO 12-way alignments version 65 can be
downloaded from the Ensembl (December 2011) at ftp://
ftp.ensembl.org/pub/release-65/emf/ensembl-compara/epo_
12_eutherian/ and http://www.ebi.ac.uk/~kbeal/species_
mapper/epo_547_hs_mm_12way_mammals_65.out.gz.
The human ChIP-Seq TFos and DHSs can be downloaded
from the Human ENCODE website at http://genome.ucsc.
edu/ENCODE/.Additional file
Additional file 1: Supplemental Figures and Tables.
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